Machine Learning In Drug Development: A Conversation With GNS Healthcare’s Iya Khalil

Supercomputing could mean major progress for pharma – particularly when the machine can predict interventions.

Compass and keyboard

GNS Healthcare Co-Founder Iya Khalil uses machine learning to reverse engineer huge amounts of data, in a way that can help speed and improve advances throughout in pharma R&D and beyond.

“I can actually do what/if simulations and simulate the impact of the intervention, simulate what happens if I have a...

More from Clinical Trials

More from R&D

Swissmedic Launches Pilot To Expedite Clinical Trial Applications

 

Swiss health care products agency Swissmedic will launch a pilot in July to fast track clinical trial applications, which the agency claims will place Switzerland at the forefront compared to other European countries.

No ‘Doomsday’ For US Pharma Despite Political Uncertainties, EU Industry Chief Says

 

While challenges in the US present an “incredible opportunity” for Europe, there is no “doomsday” happening there, Stefan Oelrich, the newly-announced president of European pharma industry federation EFPIA says.

EU Countries Rally Behind Novel Pathway For Combined Drug/IVD Trials

 
• By 

Broad participation by EU member states in a new pilot to test a unified procedure for evaluating applications for combined drug and IVD studies shows they recognize its value, says Monique Al, vice-chair of the Clinical Trials Coordination Group.